Position in NBIX
as of Mar 31, 2026
· filed Apr 29, 2026
Position Value
$76,333,976
-$6,513,040 QoQ
Shares Held
579,429
-0.8% QoQ
Ownership
0.576%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
20 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Swedbank AB holds $732,986,628 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,004,200 | $355,126,482 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
327,122 | $193,976,803 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
1,228,743 | $93,200,156 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
This page
|
579,429 | $76,333,976 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
380,266 | $11,453,611 | |
| 6 | INDV |
Indivior Pharmaceuticals, Inc.
|
95,000 | $2,895,600 |
All Filings in NBIX
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $76,333,976 | 579,429 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $82,847,016 | 584,129 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $76,834,045 | 547,329 | Shares | Defined | 2025-10-15 | |
| 2025-06-30 | $63,285,166 | 503,502 | Shares | Defined | 2025-07-10 | |
| 2024-12-31 | $1,132,540 | 8,297 | Shares | Defined | 2025-01-22 | |
| 2024-09-30 | $1,614,462 | 14,012 | Shares | Defined | 2024-10-11 | |
| 2024-06-30 | $1,929,032 | 14,012 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $1,932,535 | 14,012 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $954,469 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2023-09-30 | $814,950 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2023-06-30 | $683,109 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2023-03-31 | $733,237 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2022-12-31 | $865,223 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2022-09-30 | $769,385 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2022-06-30 | $706,145 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2022-03-31 | $679,125 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2021-12-31 | $616,971 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2021-09-30 | $694,772 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2021-06-30 | $704,986 | 7,244 | Shares | Defined | 2024-12-06 | |
| 2021-03-31 | $704,479 | 7,244 | Shares | Defined | 2024-12-06 | |
| No filing history on record for this holder in this stock. | ||||||